UK medtech startup Axis Spine Technologies, which develops Anterior Spinal Implant technology, has completed a £2.2 million fundraising. The funding was led by the first investment by the new Delta Fund from ACF Investors, with further investment coming from Mercia’s EIS funds.
Axis’ technology enables surgeons to have greater correction and alignment options during spinal procedures. The technology’s modular devices can be inserted with minimal force, in comparison to tradition implants, reducing the risk of structural damage, which can be a cause of complications such as subsidence.
The funding raised will be used to launch the company’s first implant system, the Axis-ALIF, in the USA and will also contribute to the development of Oblique, Lateral cage implants.
Axis CEO and founder John Arcos said: “In 2021 we will take a big step forward in our mission to help surgeons improve the spinal care they provide to their patients. Our products will enable them to achieve superior correction and to maintain this correction more reliably than with the devices available today.”
“We are very pleased to be the first investment from ACF Investors’ Delta Fund and to have the continued support of Mercia and our independent angel investors as we demonstrate the benefits of modular implants and expand the Axis product range.”